Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

NCT01705106 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped The study was terminated early due to slow accrual.

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: capecitabine
DRUG: celecoxib
OTHER: pharmacological study
OTHER: laboratory biomarker analysis
OTHER: pharmacogenomic studies

Sponsor

University of Chicago

Collaborators

[object Object]